中文 | English
Return
Total: 97 , 1/10
Show Home Prev Next End page: GO
Author:(Min-hang YU)

1.A Personalized Brain-computer Interface Paradigm and Decoding Method for The Objective Evaluation of Auditory Frequency Difference Limen

Sheng-Ye LI ; Xiao-Lin XIAO ; Shi-Hang YU ; Bei-Bei ZHANG ; Xing-Wei AN ; Min-Peng XU ; Dong MING

Progress in Biochemistry and Biophysics 2026;53(7):1927-1941

2.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

3.What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer's Disease?

Jinyue ZHOU ; Xiaoli SUN ; Keren WANG ; Min SHEN ; Jingbo YU ; Qi YAO ; Hang HONG ; Chunlan TANG ; Qinwen WANG

Neuroscience Bulletin 2025;41(7):1289-1301

4.Treating Type 2 Diabetic Nephropathy by Down-regulating NOX4 to Inhibit the Oxidative Stress Pathway in Mesenchymal Stem Cells

Shu-Qi FENG ; Guo-Rong JIN ; Qun-Hang XUE ; Min HE ; Ze-Hang WANG ; Jia-Xin YAO ; Long CHEN ; Yu-Jiao WANG ; An-Xiu ZHANG ; Sheng HE ; Bing-Rui ZHOU ; Jun XIE

Chinese Journal of Biochemistry and Molecular Biology 2025;41(5):730-740

5.FTO regulates resistance of triple-negative breast cancer to adriamycin through Wnt/β-catenin signaling pathway

Jin-min WU ; Yu-hang QI ; Jing-yi FANG ; Wei-zhi MU ; Zhao-lin CHEN ; Zhao-yi YANG

Chinese Pharmacological Bulletin 2025;41(12):2334-2341

6.Treating Type 2 Diabetic Nephropathy by Down-regulating NOX4 to Inhibit the Oxidative Stress Pathway in Mesenchymal Stem Cells

Shu-Qi FENG ; Guo-Rong JIN ; Qun-Hang XUE ; Min HE ; Ze-Hang WANG ; Jia-Xin YAO ; Long CHEN ; Yu-Jiao WANG ; An-Xiu ZHANG ; Sheng HE ; Bing-Rui ZHOU ; Jun XIE

Chinese Journal of Biochemistry and Molecular Biology 2025;41(5):730-740

7.Discussion of the methodology and implementation steps for assessing the causality of adverse event

Hong FANG ; Shuo-Peng JIA ; Hai-Xue WANG ; Xiao-Jing PEI ; Min LIU ; An-Qi YU ; Ling-Yun ZHOU ; Fang-Fang SHI ; Shu-Jie LU ; Shu-Hang WANG ; Yue YU ; Dan-Dan CUI ; Yu TANG ; Ning LI ; Ze-Huai WEN

The Chinese Journal of Clinical Pharmacology 2024;40(2):299-304

8.Mechanism analysis of E7766 in the treatment of bladder cancer based on network pharmacology and bioinformatics

Tian-Tian QI ; Yu-Hang ZHANG ; Yi-Min CUI

The Chinese Journal of Clinical Pharmacology 2024;40(16):2409-2412

9.Regulatory effect of physiological tensile stress on differentiation of ATDC5 chondrocytes through Nell-1/Ihh signaling pathway

Ziwei DONG ; Huichuan QI ; Jun MA ; Qing XUE ; Jinhan NIE ; Hang YU ; Min HU

Journal of Jilin University(Medicine Edition) 2024;50(1):1-9

10.Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation

Yang YI ; Wenzhe LI ; Kefang LIU ; Heng XUE ; Rong YU ; Meng ZHANG ; Yang-Oujie BAO ; Xinyuan LAI ; Jingjing FAN ; Yuxi HUANG ; Jing WANG ; Xiaomeng SHI ; Junhua LI ; Hongping WEI ; Kuanhui XIANG ; Linjie LI ; Rong ZHANG ; Xin ZHAO ; Xue QIAO ; Hang YANG ; Min YE

Journal of Pharmaceutical Analysis 2024;14(1):115-127

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 97 , 1/10 Show Home Prev Next End page: GO